Biobanco

Eva Ortega Director
T +34 917328000 (Ext 3650)
eortega@cnio.es

Técnicos de Laboratorio

Nuria Ajenjo
Daniel Alba
Inmaculada Almenara
María Jesús Artiga
Francisco De Luna
Cecilia Sobrino

CNIO Biobank − authorised by the Health Authorities of the Comunidad Autónoma de Madrid (CAM) and registered in the National Registry of Biobanks with reference B.000848 − is a ‘biobank for biomedical research purposes’, as defined by the Spanish Law 14/2007 and the Royal Decree RD 1716/2011. It is therefore defined as a public, non-profit organisation that hosts several collections of human biological samples for biomedical research, specifically in cancer and related diseases. The main objective of the CNIO Biobank is to facilitate access to human samples for researchers, ensuring that both the acquisition and use of human samples complies with all the legal and ethical principles that protect donors’ rights.

In addition to this biobanking activity, a number of services have been implemented, both for sample processing and for supporting different aspects of the management of human samples for biomedical research, in order to facilitate the use of human samples for CNIO researchers.

CNIO Biobank is a founder member of the Spanish Biobank Network, a project funded by the Instituto de Salud Carlos III, ISCIII, currently through the Acción Estratégica en Salud – AES 2017 supportive platforms for research programmes. CNIO Biobank leads and/or participates in many different projects such as: centralised request management system (design and development); ethical, legal and social issues (ELSI); harmonisation; biospecimen science; and marketing plans.

Therefore, CNIO Biobank is a cross-service platform for CNIO researchers, as well as the general scientific community, and is geared towards the promotion of biomedical research in cancer and related diseases.

Publicaciones

Romero-Blanco C, Artiga González MJ, Gómez-Cabello A, Vila-Maldonado S, Casajús JA, Ara I, Aznar S (2020). ACTN3 R577X Polymorphism Related to Sarcopenia and Physical Fitness in Active Older Women. Climacteric 30, 1-6. Publicación CNIO.
Devereux L, Watson PH, Mes-Masson AM, Luna-Crespo F, Thomas G, Pitman H, Speirs V, Hall AG, Bollinger N, Posada M, Lochmüller H, Thorne H, Eng CB, Riegman PHJ, Ng W, Parry-Jones A (2019). A Review of International Biobanks and Networks: Success Factors and Key Benchmarks-A 10-Year Retrospective Review.. Biopreservation & Biobanking 17, 512-519. Publicación CNIO.
Esteva-Socias M, Artiga MJ, Bahamonde O, Belar O, Bermudo R, Castro E, Escámez T, Fraga M, Jauregui-Mosquera L, Novoa I, Peiró-Chova L, Rejón JD, Ruiz-Miró M, Vieiro-Balo P, Villar-Campo V, Zazo S, Rábano A, Villena C (2019). In Search of an Evidence-Based Strategy for Quality Assessment of Human Tissue Samples: Report of the Tissue Biospecimen Research Working Group of the Spanish Biobank Network. J Transl Med 17, 370. Publicación CNIO. Open Access
Zagorac I, Fernandez-Gaitero S, Penning R, Post H, Bueno MJ, Mouron S, Manso L, Morente MM, Alonso S, Serra V, Muñoz J, Gómez-López G, Lopez-Acosta JF, Jimenez-Renard V, Gris-Oliver A, Al-Shahrour F, Piñeiro-Yañez E, Montoya-Suarez JL, Apala JV, Moreno-Torres A, Colomer R, Dopazo A, Heck AJR, Altelaar M, Quintela-Fandino M (2018). In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer. Nat Commun 9, 3501. Publicación CNIO. Open Access
Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore HM, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G (2017). Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.. Biopreservation & Biobanking 15, 270-276. Publicación CNIO.
Manso L, Mourón S, Tress M, Gómez-López G, Morente M, Ciruelos E, Rubio-Camarillo M, Rodriguez-Peralto JL, Pujana MA, Pisano DG, Quintela-Fandino M (2016). Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance.. PLoS ONE 11, e0155840. Publicación CNIO.
Suárez AE, Artiga MJ, Santonja C, Montes-Moreno S, De Pablo P, Requena L, Piris MA, Rodríguez-Pinilla SM (2016). Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression.. J Cutan Pathol 43, 1203-1210. Publicación CNIO.
Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore H, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G (2016). Annual Conference of the National Infrastructures for Biobanking. Biopreservation & Biobanking (in press). Publicación CNIO.
García-Donas J, Beuselinck B, Inglada-Pérez L, Graña O, Schöffski P, Wozniak A, Bechter O, Apellániz-Ruiz M, Leandro-García LJ, Esteban E, Castellano DE, González Del Alba A, Climent MA, Hernando S, Arranz JA, Morente M, Pisano DG, Robledo M, Rodriguez-Antona C. (2016). Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.. JCI Insight 7, e86051. Publicación CNIO.

Biobanco

El Biobanco CNIO (autorizado por la Consejería de Salud de la Comunidad de Madrid y número de registro B.000848 en el Registro Nacional de Biobancos) es un biobanco para investigación biomédica de acuerdo a la definición establecida en la Law 14/2007, de 3 de julio, de investigación biomédica y en el RD 1716/2011 de 18 de noviembre que la desarrolla; que lo define como una organización sin ánimo de lucro que aloja diferentes colecciones de muestras humanas para investigación biomédica con criterios de calidad y orden.